Published online Dec 16, 2013. doi: 10.4253/wjge.v5.i12.595
Revised: November 1, 2013
Accepted: November 15, 2013
Published online: December 16, 2013
Processing time: 98 Days and 12.2 Hours
AIM: To evaluate whether the use of real time viewer (RTV) and administration of domperidone to patients with delayed gastric passage of the capsule could reduce the rate of incomplete examinations (IE) and improve the diagnostic yield of small bowel capsule endoscopy (SBCE).
METHODS: Prospective single center interventional study, from June 2012 to February 2013. Capsule location was systematically checked one hour after ingestion using RTV. If it remained in the stomach, the patient received 10 mg domperidone per os and the location of the capsule was rechecked after 30 min. If the capsule remained in the stomach a second dose of 10 mg of domperidone was administered orally. After another 30 min the position was rechecked and if the capsule remained in the stomach, it was passed into the duodenum by upper gastrointestinal (GI) endoscopy. The rate of IE and diagnostic yield of SBCE were compared with those of examinations performed before the use of RTV or domperidone in our Department (control group, January 2009 - May 2012).
RESULTS: Both groups were similar regarding age, sex, indication, inpatient status and surgical history. The control group included 307 patients, with 48 (15.6%) IE. The RTV group included 82 patients, with 3 (3.7%) IE, P = 0.003. In the control group, average gastric time was significantly longer in patients with IE than in patients with complete examination of the small bowel (77 min vs 26 min, P = 0.003). In the RTV group, the capsule remained in the stomach one hour after ingestion in 14/82 patients (17.0%) vs 48/307 (15.6%) in the control group, P = 0.736. Domperidone did not significantly affect small bowel transit time (260 min vs 297 min, P = 0.229). The capsule detected positive findings in 39% of patients in the control group and 49% in the RTV group (P = 0.081).
CONCLUSION: The use of RTV and selective administration of domperidone to patients with delayed gastric passage of the capsule significantly reduces incomplete examinations, with no effect on small bowel transit time or diagnostic yield.
Core tip: Incomplete small bowel capsule endoscopy (SBCE) is an important limitation of the technique and may occur in up to 20% of patients. Delayed gastric passage of the capsule is a major factor leading to incomplete SBCE. Selective administration of oral domperidone to patients with delayed gastric passage of the capsule assessed with the real time viewer (RTV) effectively reduces the rate of incomplete SBCE. The administration of domperidone does not influence small bowel transit time of the capsule. There is an overall trend towards higher diagnostic yield of SBCE when domperidone is selectively administered. The use of the RTV should be adopted systematically in patients undergoing small bowel capsule endoscopy.